Patents by Inventor Fabien Lux

Fabien Lux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
    Patent number: 10364274
    Abstract: The present invention encompasses vaccines or compositions comprising the chimeric KSAC protein that possesses immunogenic and protective properties, and methods of use including administering to an animal the antigenic KSAC protein thereof to protect animals. The invention also encompasses methods for making and producing the soluble, disaggregated, refolded or active proteins from inclusion bodies produced from prokaryotes or eukaryotes.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: July 30, 2019
    Assignee: BOEHRINGER INGELHEIM ANIMAL HEATLH USA INC.
    Inventors: Laurent Bernard Fischer, Nicolas Pierre Yves Carboulec, Fabien Lux
  • EXPRESSION OF CHIMERIC KSAC PROTEIN AND METHOD OF PRODUCING SOLUBLE PROTEINS BY HIGH PRESSURE
    Publication number: 20170081372
    Abstract: The present invention encompasses vaccines or compositions comprising the chimeric KSAC protein that possesses immunogenic and protective properties, and methods of use including administering to an animal the antigenic KSAC protein thereof to protect animals. The invention also encompasses methods for making and producing the soluble, disaggregated, refolded or active proteins from inclusion bodies produced from prokaryotes or eukaryotes.
    Type: Application
    Filed: February 5, 2016
    Publication date: March 23, 2017
    Applicant: MERIAL INC.
    Inventors: Laurent Bernard Fischer, Nicolas Pierre Yves Carboulec, Fabien Lux
  • Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
    Patent number: 9315553
    Abstract: The present invention encompasses vaccines or compositions comprising the chimeric KSAC protein that possesses immunogenic and protective properties, and methods of use including administering to an animal the antigenic KSAC protein thereof to protect animals. The invention also encompasses methods for making and producing the soluble, disaggregated, refolded or active proteins from inclusion bodies produced from prokaryotes or eukaryotes.
    Type: Grant
    Filed: August 30, 2013
    Date of Patent: April 19, 2016
    Assignee: MERIAL, INC.
    Inventors: Laurent Bernard Fischer, Nicolas Pierre Yves Carboulec, Fabien Lux
  • Methods for producing methionine by culturing a microorganism modified to enhance production of cysteine
    Patent number: 9187775
    Abstract: A method of producing methionine, derivatives or precursors thereof includes culturing a modified microorganism in a culture medium comprising a source of carbon and a source of sulfur; and recovering methionine from the culture medium, wherein said modified microorganism has an increased expression of cysE gene encoding serine acetyltransferase, metH gene encoding methionine synthase and metF gene encoding 5,10-methylenetetrahydrofolate reductase compared to expression of the cysE, metH and metF genes in an unmodified microorganism.
    Type: Grant
    Filed: January 9, 2013
    Date of Patent: November 17, 2015
    Assignee: Metabolic Explorer
    Inventors: Rainer Figge, Fabien Lux, Céline Raynaud, Michel Chateau, Philippe Soucaille
  • EXPRESSION OF CHIMERIC KSAC PROTEIN AND METHOD OF PRODUCING SOLUBLE PROTEINS BY HIGH PRESSURE
    Publication number: 20140072594
    Abstract: The present invention encompasses vaccines or compositions comprising the chimeric KSAC protein that possesses immunogenic and protective properties, and methods of use including administering to an animal the antigenic KSAC protein thereof to protect animals. The invention also encompasses methods for making and producing the soluble, disaggregated, refolded or active proteins from inclusion bodies produced from prokaryotes or eukaryotes.
    Type: Application
    Filed: August 30, 2013
    Publication date: March 13, 2014
    Applicant: MERIAL LIMITED
    Inventors: Laurent Bernard Fischer, Nicolas Pierre Yves Carboulec, Fabien Lux
  • Methods for producing methionine by culturing a microorganism modified to enhance production of cysteine
    Patent number: 8389250
    Abstract: A method of producing methionine, derivatives or precursors thereof comprising culturing a microorganism modified to enhance production of cysteine in a culture medium comprising a source of carbon and a source of sulfur and recovering methionine from the culture medium. A microorganism for fermentative production of methionine or its derivatives in which production of methionine or derivatives thereof, wherein the microorganism enhances production of cysteine.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: March 5, 2013
    Assignee: Metabolic Explorer
    Inventors: Rainer Figge, Fabien Lux, Céline Raynaud, Michel Chateau, Philippe Soucaille
  • Methods for Producing Methionine by Culturing a Microorganism Modified to Enhance Production of Cysteine
    Publication number: 20080311632
    Abstract: A method of producing methionine, derivatives or precursors thereof comprising culturing a microorganism modified to enhance production of cysteine in a culture medium comprising a source of carbon and a source of sulfur and recovering methionine from the culture medium. A microorganism for fermentative production of methionine or its derivatives in which production of methionine or derivatives thereof, wherein the microorganism enhances production of cysteine.
    Type: Application
    Filed: January 4, 2006
    Publication date: December 18, 2008
    Inventors: Rainer Figge, Fabien Lux, Celine Raynaud, Michel Chateau, Philippe Soucaille
  • METHOD FOR PRODUCING K5 POLYSACCHARIDE
    Publication number: 20080032349
    Abstract: The invention concerns a method for producing K5 polysaccharide, comprising a fermentation step from Escherichia coli followed by a purification step.
    Type: Application
    Filed: March 8, 2007
    Publication date: February 7, 2008
    Applicant: Aventis Pharma S.A.
    Inventors: Christian Viskov, Fabien Lux, Regis Gervier, Gilles Colas